Last reviewed · How we verify
Chitin microparticles by nasal route — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Chitin microparticles by nasal route (Chitin microparticles by nasal route) — CMP Therapeutics Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Chitin microparticles by nasal route TARGET | Chitin microparticles by nasal route | CMP Therapeutics Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Chitin microparticles by nasal route CI watch — RSS
- Chitin microparticles by nasal route CI watch — Atom
- Chitin microparticles by nasal route CI watch — JSON
- Chitin microparticles by nasal route alone — RSS
Cite this brief
Drug Landscape (2026). Chitin microparticles by nasal route — Competitive Intelligence Brief. https://druglandscape.com/ci/chitin-microparticles-by-nasal-route. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab